Professor Maria Kyrgiou is a Professor and Consultant Gynaecologic Oncology Surgeon in Gynaecology at Imperial College London and Imperial College NHS Trust.

She has trained in obstetrics and gynaecology and subsequently specialised in gynaecological oncology and advanced minimal access at the West London Gynaecological Cancer Centre at Imperial College Healthcare NHS Trust.

The main focus of her academic interests has been in translational research in gynaecological diseases and cancers, with a particular interest in prevention and early detection of gynaecological malignancies. She has investigated the role of treatment of cervical cancer and precancer in reproductive outcomes and the clinical use of HPV biomarkers in personalising the management of women with abnormal findings at screening. She has developed an interest on the role of microbiome and host interactions in gynaecological cancer. She works on the role of obesity and metabolic disorders in endometrial cancer. She is the chief investigator of the NOVEL trial assessing the value of HPV vaccination after local treatment for cervical pre-invasive disease.

Professor Kyrgiou is recognised nationally and internationally for her research and has published extensively in the field of gynaecologic oncology. She contributes to a number of national and international committees, such as the ESGO Prevention Committee and chairs the BSCCP Research Committee.